Madhushankha Madhawa, Jayarajah Umesh, Abeygunasekera Anuruddha M
Faculty of Medicine, University of Colombo Sri Lanka.
Department of Urology, National Hospital of Sri Lanka Colombo, Sri Lanka.
Am J Clin Exp Urol. 2021 Feb 15;9(1):1-17. eCollection 2021.
Hematospermia is an uncommon symptom but can cause significant anxiety among the patient and his partner. The available data on the underlying etiology, management and outcome are variable and inconsistent. This systematic review was aimed to describe the clinical characteristics, etiology, treatment and outcomes of hematospermia.
Keywords were searched in PubMed, Scopus, LILACS and Google Scholar. Relevant articles were manually added from the list of references of eligible articles. Studies with a considerable assessment of patients with hematospermia were included. Qualitative analysis was performed using the available data.
Twenty studies (Fifteen prospective and five retrospective, n=2079 patients, mean age =46.2 (range: 15-89) years) were eligible. Community screening reported a 0.5% prevalence of hematospermia (one study). Majority had hematospermia as the main/only symptom while dysuria (n=38/232, 16.4%), lower urinary tract symptoms (n=113/833, 13.6%), Hematuria (65/566, 11.5%) and testicular pain (n=68/631, 10.7%), were associated in some patients. Suspicious rectal examination (one study) and elevated PSA (Prostate Specific Antigen) levels (four studies) were indicative of sinister pathologies. Common etiologies were urogenital infections/inflammatory conditions followed by prostatic, seminal vesicular or urethral calculi. Malignancies were detected in 5.4% (n=74/1362, 11 studies) of patients >40 years old and the majority had prostate cancers (67/74, 90.5%). Etiology was unknown in 51.8% (n=603/1163). Definitive treatment of the underlying etiology (n=260/347, 74.9%) resolved the symptoms while spontaneous resolution occurred in the vast majority 88.9% (n=168/189) with unknown etiology.
Hematospermia is relatively an innocent symptom. Malignancies are rare and occurred in men over 40 years. Clinical assessment including a rectal examination and a PSA level would be sufficient to identify most causes. Urogenital infections/inflammation and prostatic calculi are the commonly found etiologies. There was no identifiable cause in almost half of those with hematospermia. The majority has a benign course.
血精是一种不常见的症状,但会引起患者及其伴侣的严重焦虑。关于其潜在病因、治疗及预后的现有数据存在差异且不一致。本系统评价旨在描述血精的临床特征、病因、治疗及预后。
在PubMed、Scopus、LILACS和谷歌学术中检索关键词。从符合条件的文章参考文献列表中手动添加相关文章。纳入对血精患者进行充分评估的研究。使用现有数据进行定性分析。
20项研究(15项前瞻性研究和5项回顾性研究,n = 2079例患者,平均年龄 = 46.2岁(范围:15 - 89岁))符合要求。社区筛查报告血精患病率为0.5%(一项研究)。大多数患者以血精为主要/唯一症状,而部分患者伴有排尿困难(n = 38/232,16.4%)、下尿路症状(n = 113/833,13.6%)、血尿(65/566,11.5%)和睾丸疼痛(n = 68/631,10.7%)。可疑直肠指检(一项研究)和前列腺特异性抗原(PSA)水平升高(四项研究)提示存在严重病变。常见病因是泌尿生殖系统感染/炎症,其次是前列腺、精囊或尿道结石。在年龄大于40岁的患者中,5.4%(n = 74/1362,11项研究)检测到恶性肿瘤,其中大多数为前列腺癌(67/74,90.5%)。51.8%(n = 603/1163)的患者病因不明。对潜在病因进行明确治疗(n = 260/347,74.9%)可缓解症状,而病因不明的患者中绝大多数(88.9%,n = 168/189)症状可自发缓解。
血精相对来说是一种良性症状。恶性肿瘤罕见且发生于40岁以上男性。包括直肠指检和PSA水平检测在内的临床评估足以确定大多数病因。泌尿生殖系统感染/炎症和前列腺结石是常见病因。几乎一半血精患者病因不明。大多数患者病程呈良性。